Chemotherapy for cancer of the uterine body usually comes after surgery, not instead of it, and many women first hear of it from the pathology report. The first question is always: why, if the uterus is gone?
Below: what chemotherapy for uterine cancer in Germany is for, who needs it and who does not, what a course involves and how it feels. Other treatments are covered on the page on uterine cancer treatment in Germany.
Who is offered drug treatment
Not everyone needs drug treatment: it depends on what the pathologist found in the removed tumour. In early, low-grade cancer, follow-up after surgery is often enough, and that too is a proper decision. Chemotherapy is discussed if the tumour is aggressive in type or grade, has grown deep, spread beyond the uterus or reached the lymph nodes. For the operation, see surgery for uterine cancer.
The second situation is advanced or returning disease that surgery or radiotherapy cannot remove locally. Drug treatment then becomes the main treatment, and the goal changes: holding the disease back and keeping the woman feeling well, not “removing everything”.
The third situation is treatment before surgery, if the tumour is large from the start or cannot be fully removed. For some types of uterine cancer, radiotherapy follows surgery instead of chemotherapy, or the two are combined; the tumour board decides. Hormone-dependent tumours have another route: hormone therapy in oncology.
What is looked for in the tumour before treatment
The decision rests on the tumour itself, not only the stage. The key lines in the pathology report are type and grade, hormone receptors, the state of the system that fixes errors in a cell’s DNA (written as MMR or MSI) and sometimes wider molecular testing. They decide whether the talk is of chemotherapy, hormones or adding immunotherapy.
So patients are asked to bring the slides and tissue blocks: some tests are done on the same material, and a German pathologist reviews the diagnosis, sometimes changing the plan. A clear account in English: material on endometrial cancer prepared with the Cancer Information Service of the German Cancer Research Center.
How a course is organised
Chemotherapy runs in cycles: a day or two of infusions, a break to recover, then a repeat. The treating doctor states the number of cycles. In cancer of the uterine body, the backbone is usually a platinum drug combined with a taxane.
Courses are mostly outpatient, in an oncology department’s day clinic or a specialised oncology practice. In Munich, for example, the Münchner Onkologie practice, run by Dr Daniela Grenacher-Horn, a specialist in internal oncology, haematology and drug treatment of tumours, gives them in its own day clinic. Many patients get a port, a small chamber under the skin below the collarbone linked to a large vein: infusions go through it, so no vein has to be found each cycle and the veins are spared.
A blood test comes before every infusion; low counts mean a delay. After several cycles there is a check-up CT or MRI, and a fever means calling the department at once. The break is part of treatment, not a pause: blood formation recovers. More on the page on chemotherapy in Germany.
Side effects and what is done about them
The usual side effects are nausea, tiredness, hair loss, falling blood counts and numbness in fingers and toes from taxanes. German departments prescribe supportive treatment in advance, not “when things get bad”.
Anti-sickness drugs start before the infusion. Some centres cool the scalp, which can limit hair loss with taxanes. Blood counts are monitored; if white cells fell so low that fever followed or treatment was delayed, drugs that boost their production are given before later cycles, but low white cells alone, without fever, are no reason for them. Numbness is asked about before each cycle; if it appears, the treating doctor changes the dose.
Much also depends on the patient: a dentist visit before the course to prevent mouth infections, sensible eating, enough fluids, gentle daily exercise and a symptom diary. If the woman is young and the question matters to her, contraception during treatment and preserving fertility are discussed before the first cycle.
After the course: follow-up and recovery
A course ends with a check-up and a written report with a follow-up plan for the doctor at home. It gives the timing of examinations, more frequent at first, and says when imaging is needed: without symptoms, CT and MRI are usually not scheduled but ordered for complaints.
Tiredness lifts slowly and may last long after the last cycle; physiotherapy and oncological rehabilitation help. Psychological support matters too: anxiety after cancer treatment is understandable, and a psycho-oncologist can help, during the course and after.
Frequently asked questions
Is chemotherapy always needed after surgery for uterine cancer?
No, not every woman needs it. It depends on the removed tumour: early, low-grade cancer often needs only follow-up, and some tumours get radiotherapy instead. Chemotherapy is discussed for aggressive types or tumours that have grown deep, spread beyond the uterus or reached the lymph nodes.
How long does chemotherapy for uterine cancer last?
Usually several months. The course consists of cycles, each followed by a recovery break. The doctor explains in advance how many cycles are planned and how often. If blood counts have not recovered by the next cycle, it is postponed and the course stretches.
Will I lose my hair during chemotherapy for uterine cancer?
Most likely yes: taxanes usually cause hair loss. Once the course is over, hair usually grows back. Some German centres offer scalp cooling during the infusion, which can reduce hair loss with these drugs. It helps to choose a wig or headscarf before the first cycle.
How AlenMed arranges the treatment
First the documents: the histology report with slides and blocks, the operation report, recent test results and the CT or MRI go to the department, with the reports translated by AlenMed. The doctor says whether drug treatment is indicated, how many cycles are discussed and whether treatment can continue at home between cycles. Then come a written estimate, the visa invitation, appointments and an interpreter. For costs, see the page on the cost of uterine cancer treatment.
Treatment takes months, so it is agreed in advance which cycles take place in Germany and which at home, and who supervises in between. Plan accommodation near the hospital and a companion: after an infusion it is better not to travel alone.
This material is for information only and is not an offer. A doctor decides the treatment plan in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.


